Lepu Medical was founded in 1999 and listed on the Shenzhen Stock Exchange in 2009. The company is mainly engaged in the research and development of cardiovascular interventional devices and cardiovascular drugs for coronary artery stents, congenital occlusion devices, heart valves and contrast machines. Production and sales. The clinical application of the product covers more than 1,200 cardiac treatment centers nationwide. After 18 years of hard work in the Chinese market, Lepu Medical's cardiovascular health industry chain includes four major business segments: medical devices, pharmaceuticals, medical services and strategic businesses, covering the most promising segments and relying on them. The accumulated customer resources and industry experience in the industry have gradually become the aircraft carrier in China's cardiovascular field.
Layout four business segments to nurture China's cardiovascular industry chain ecosystem
medical instruments
Including cardiovascular devices, IVD, surgical instruments, smart medical devices, etc. Among them, the company focuses on the development of IVD, and actively explores liquid biopsy, vascular dialysis and other fields. In the future, new products such as fully absorbable stents, dual-chamber pacemakers, left atrial appendage occlusion devices, and surgical instruments will become the company's long-term growth. .
drug
Including antithrombotic drugs, anti-heart failure drugs, hypolipidemic drugs, hypoglycemic drugs; and antihypertensive drugs that are expected to be intervened through acquisitions in the future. In 2013, the company acquired 60% equity of Xinshuike (Lepu Pharmaceutical). In March 2016, it became a wholly-owned subsidiary of the company. In 2014, it acquired Haihetian and Xindonggang. In the future, the company will improve and improve the cardiovascular drug product line. .
medical service
Including the heart center department co-construction, cardiovascular hospitals, grassroots hospitals, cardiovascular and cerebrovascular network hospitals, and precision medical services. In 2016, the company invested RMB 93.2 million to acquire 100% equity of Luoyang Sixth Hospital. It is the first specialist hospital project to be launched. It will invest at 3-5 hospitals per year in the future; the company has been in Shandong, Henan, Hebei, Liaoning, More than 100 primary hospitals in Shanxi and Shaanxi have set up a number of interventional medical centers, and plans to increase the number of 300 county-level hospital departments in the next three years.
Strategic business
Including small equity investment, Lepu financial, Internet medical three major parts. The company's Internet medical business is an excellent example of A-shares, which is not practical, gradually realized, and business synergy. It consists of mobile medical hardware portal, patient cloud health community, Internet network hospital, and vertical e-commerce. The company's cardiovascular network hospital has now entered 223 primary clinics, with more than 2,000 patients per week, and five provincial-level regional cardiovascular networks within three years.
Lepu Medical Health Whole Industry Chain Platform
Polarizing Microscope ,Polarized Light Microscopy,Polarized Optical Microscopy,Polarised Light Microscopy
Ningbo ProWay Optics & Electronics Co., Ltd. , https://www.proway-microtech.com